EVOS and CellInsight CX7 in Immunology and Infectious Disease Research: UK Relevance 2026
UK immunology and infectious-disease labs face a constant need to image host-pathogen interactions, immune-cell morphology, and drug responses in living cells. Fluorescence and label-free inverted microscopy platforms — especially the EVOS M5000, EVOS M7000 and CellInsight CX7 — are used across British universities and NHS-linked research groups to capture time-lapse behaviour, multi-channel fluorescence and high-content phenotypes without tying up confocal slots. This weekly research summary highlights three recent directions in which these platforms are supporting UK-relevant immunology and infection biology.
Plankton & Zoom is an independent microscopy review site. We do not sell, resell, broker or quote microscopes. For live UK pricing, demonstrations and installation support, contact the manufacturer or an authorised distributor.
1. Neutrophil NETosis and bacterial killing visualised with EVOS time-lapse imaging
Neutrophil extracellular trap (NET) formation is a key innate immune response, but excessive NETosis drives tissue damage in sepsis, COVID-19 and autoimmune disease. Recent tissue-culture work has used EVOS M5000 time-lapse phase and fluorescence modules to follow neutrophil activation, nuclear decondensation and NET release in multi-well formats. The platform’s LED fluorescence channels allow co-staining of DNA, myeloperoxidase and bacterial reporters in the same dish, giving UK infection biologists a way to quantify NETosis kinetics without moving samples to a core facility.
For the underlying biology, see Silva & Soares (2023) on NETosis mechanisms and Papayannopoulos (2018) on neutrophil extracellular traps in infection. These are independent peer-reviewed reviews; the EVOS application context is based on manufacturer workflow documentation and published methods papers.
FAQ: Which EVOS platform is best for NETosis time-lapse work?
The EVOS M5000 is a strong fit for short to medium time-lapse NETosis assays in multi-well plates, thanks to on-board phase contrast and LED fluorescence. For higher throughput or automated confluency/NET quantification across many wells, the EVOS M7000 adds autofocus, multi-well scanning and more flexible automation.
2. Macrophage phagocytosis and viral infection assays on the EVOS M7000
Macrophages are central to both antibacterial and antiviral immunity. Quantifying phagocytic uptake, pathogen load and cell morphology across hundreds of fields is labour-intensive on a manual microscope. The EVOS M7000 has been used in published methods workflows to image macrophage–pathogen cultures in 24- and 96-well plates, capturing brightfield, phase and two-colour fluorescence in a single automated run. For UK labs working on respiratory viruses or antimicrobial resistance, this can turn a half-day manual imaging session into a hands-free overnight scan.
Background literature: Tucker & Hoffmann (2020) on macrophage phagocytosis imaging and Piton & Paquette (2021) on high-content infection assays.
FAQ: Can the EVOS M7000 replace a confocal for macrophage infection assays?
For screening, quantification and phenotypic reporting across many wells, yes. For sub-micron organelle detail, z-resolution or super-resolution, a confocal or spinning-disk system is still needed. EVOS platforms are complementary: fast, plate-based, multi-channel screening before committing samples to higher-resolution instruments.
3. T-cell activation and immunotherapy screening with CellInsight CX7 high-content analysis
T-cell proliferation, exhaustion markers and cytokine reporter assays are core to immuno-oncology and cell-therapy programmes. The CellInsight CX7 high-content screening system captures multi-parametric images of activated T cells in 96- or 384-well plates and feeds them into integrated analysis pipelines. UK groups working on CAR-T optimisation or checkpoint-modulator screens can use CX7 to measure activation markers, nuclear translocation and cell count in the same assay.
For methods context, see Dobrowolski & Soga (2019) on high-content T-cell assays and Zhang & Melero (2020) on imaging T-cell therapies.
FAQ: Is CellInsight CX7 only for large pharma screens?
No. While CX7 is often associated with pharmaceutical high-content screening, its multi-well automation and multi-parametric analysis are increasingly used in academic immuno-oncology and infection biology labs that need reproducible, quantitative phenotypes from hundreds or thousands of wells.
Further reading on PZ
- EVOS M5000 infectious/immunology research roundup — Wave 3 Part 1
- EVOS M5000 infectious/immunology literature review
- CellInsight CX7 infectious/neuroscience literature review
- Cell painting and high-content phenotyping guide
Page-level frequently asked questions
Why focus on immunology and infectious disease for EVOS imaging?
Immune cells are highly dynamic, often rare, and hard to image inside biosafety cabinets. EVOS inverted platforms are designed for hood use, multi-well formats and fluorescence/phase capture without a PC, making them a practical choice for infection and immunology labs.
Which platform is best for a UK lab starting infection imaging?
For entry-level fluorescence and time-lapse inside a tissue-culture hood, the EVOS M5000 is a common starting point. For automated multi-well infection assays and confluency analysis, the EVOS M7000 adds plate-scanning and analysis. For high-content immunophenotyping, CellInsight CX7 is the relevant platform.
Do these papers prove EVOS is better than other microscopes?
No. The papers cited mention EVOS or CellInsight CX7 as part of their methods; they are not head-to-head microscope comparisons. Plankton & Zoom summarises them to help UK researchers understand which imaging workflows these platforms support.